In TCGA-BLCA dataset, higher mRNA levels of GFPT1, GFPT2, PGM3, and UAP1 in Stage III–IV than those in Stage I–II were observed (Figure 1D). The gene discussed is PGM3; the disease is bladder transitional cell carcinoma.